Modeling of synthetic phosphono and carba analogues of N-acetyl-alpha-D-mannosamine 1-phosphate, the repeating unit of the capsular polysaccharide from Neisseria meningitidis serovar A.

The conformational behavior of methyl (2-acetamido-2-deoxy-alpha-d-mannopyranosyl)phosphate 1, and its analogues, methyl C-(2-acetamido-2-deoxy-alpha-d-mannopyranosyl)methanephosphonate 2 and methyl O-(2-acetamido-2-deoxy-5a-carba-alpha-d-mannopyranosyl)phosphate , where a methylene group replaces, respectively, the anomeric and the pyranose oxygen atom, was investigated at the B3LYP/6-311+G(d,p) level [6-311+G(2df,p) for the phosphorus atom]. The energy of the optimized structures was recalculated using the continuum solvent model C-PCM choosing water as the solvent. The compounds exhibited several populated conformations, but they all showed a marked preference for the (4)C(1) geometry of the pyranose ring; this preference was almost complete for 1, very large for the phosphono analogue 2, and large for the carba analogue 3. To give experimental support to these results, compounds 2 and 3 were synthesized and characterized by NMR spectroscopy. The comparison of the theoretical and experimental vicinal coupling constants confirmed the marked preference for the (4)C(1) geometry in the case of 2 and suggested that the same holds true for compound 3.

[1]  D. Bundle,et al.  Determination of the structure and conformation of bacterial polysaccharides by carbon 13 nuclear magnetic resonance. Studies on the group-specific antigens of Neisseria meningitidis serogroups A and X. , 1974, The Journal of biological chemistry.

[2]  A. Sudha,et al.  Carbohydrates to carbocycles: an expedient synthesis of pseudo-sugars , 1998 .

[3]  R. Schneerson,et al.  Effect of the nonreducing end of Shigella dysenteriae type 1 O-specific oligosaccharides on their immunogenicity as conjugates in mice , 2007, Proceedings of the National Academy of Sciences.

[4]  A. Marra,et al.  Methods for anomeric carbon-linked and fused sugar amino Acid synthesis: the gateway to artificial glycopeptides. , 2000, Chemical reviews.

[5]  L. Pannell,et al.  Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Compain,et al.  Carbohydrate mimetics-based glycosyltransferase inhibitors. , 2001, Bioorganic & medicinal chemistry.

[7]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[8]  A. Pollard,et al.  Vaccine prevention of meningococcal disease, coming soon? , 2001, Vaccine.

[9]  I. V. Botvinko,et al.  Natural phosphoglycans containing glycosyl phosphate units: structural diversity and chemical synthesis. , 2007, Carbohydrate research.

[10]  A. Becke.  Density-functional thermochemistry. III. The role of exact exchange , 1993 .

[11]  D. Werz,et al.  Total synthesis of antigen bacillus anthracis tetrasaccharide--creation of an anthrax vaccine candidate. , 2005, Angewandte Chemie.

[12]  J. Faro,et al.  Immune responses to polysaccharides: lessons from humans and mice. , 2008, Vaccine.

[13]  D. Werz,et al.  Anti-carbohydrate antibodies for the detection of anthrax spores. , 2006, Angewandte Chemie.

[14]  O. Arjona,et al.  Synthesis and conformational and biological aspects of carbasugars. , 2007, Chemical reviews.

[15]  F. Compostella,et al.  A theoretical study of the conformational behavior of analogues of α-l-rhamnose-1-phosphate , 2004 .

[16]  R. Engel.  Phosphonates as analogues of natural phosphates , 1977 .

[17]  Jacopo Tomasi,et al.  Geometry optimization of molecular structures in solution by the polarizable continuum model , 1998 .

[18]  W. Zou.  C-glycosides and aza-C-glycosides as potential glycosidase and glycosyltransferase inhibitors. , 2005, Current topics in medicinal chemistry.

[19]  R. Roy,et al.  A Synthetic Conjugate Polysaccharide Vaccine Against Haemophilus influenzae Type b , 2004, Science.

[20]  A. Pollard,et al.  Vaccines against bacterial meningitis. , 2004, British medical bulletin.

[21]  G. Boons,et al.  Synthesis and antigenic analysis of the BclA glycoprotein oligosaccharide from the Bacillus anthracis exosporium. , 2006, Chemistry.

[22]  V. Pozsgay.  Oligosaccharide-protein conjugates as vaccine candidates against bacteria. , 2000, Advances in carbohydrate chemistry and biochemistry.

[23]  A. Pollard,et al.  Meningococcal polysaccharide-protein conjugate vaccines. , 2005, The Lancet. Infectious diseases.

[24]  C. Jones,et al.  An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b. , 2000, Biologicals : journal of the International Association of Biological Standardization.

[25]  F. Compostella,et al.  (α‐L‐Rhamnopyranosyl)methylphosphonic Acids: Experimental Evidence of the Analogy with α‐L‐Rhamnopyranosyl Phosphate , 2005 .

[26]  A. Pollard,et al.  Development of natural immunity to Neisseria meningitidis. , 2001, Vaccine.

[27]  R. Rappuoli,et al.  A universal vaccine for serogroup B meningococcus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. D. Leeuw,et al.  The relationship between proton-proton NMR coupling constants and substituent electronegativities—I : An empirical generalization of the karplus equation , 1980 .

[29]  G. Lombardi,et al.  Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A. , 2007, Chemistry.